ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Evogene Ltd

Evogene Ltd (EVGN)

1,65
0,00
(0,00%)
Fermé 21 Novembre 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
1,65
Prix Achat
1,60
Prix Vente
1,74
Volume échangé
-
0,00 Fourchette du Jour 0,00
1,56 Plage de 52 semaines 10,40
Cap du marché
Clôture Veille
1,65
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
292 287
Actions en circulation
5 079 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,35
Bénéfice par action (BPA)
-4,7
Chiffre d'affairess
5,64M
Bénéfice net
-23,88M

À propos de Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB plat... Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment. Show more

Secteur
Agricultural Chemicals
Industrie
Biological Pds,ex Diagnstics
Site Web
Siège social
Rehovot, Center, Isr
Fondé
2011
Evogene Ltd est coté dans le secteur Agricultural Chemicals de la NASDAQ avec le ticker EVGN. Le dernier cours de clôture d'Evogene était de US$1,65. Au cours de la dernière année, les actions de Evogene ont été négociées dans une fourchette de prix de US$ 1,56 à US$ 10,40.

Evogene compte actuellement 5 079 000 actions en circulation. La capitalisation boursière d'Evogene est de US$8,38 million. Evogene a un ratio cours/bénéfice (ratio PE) de -0.35.

EVGN Dernières nouvelles

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results PR Newswire REHOVOT, Israel, Nov. 19, 2024...

Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials

Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials PR Newswire REHOVOT, Israel, Nov. 12, 2024 Lavie Bio intends to commence Yalos®...

Evogene Schedules Third Quarter 2024 Financial Results Release

Evogene Schedules Third Quarter 2024 Financial Results Release PR Newswire REHOVOT, Israel, Nov. 7, 2024 Zoom conference call scheduled for November 21, 2024, 9:00 AM ET REHOVOT, Israel, Nov. 7...

Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design

Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design PR Newswire REHOVOT, Israel, Oct. 31, 2024 The collaboration has the...

Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya

Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya PR Newswire REHOVOT, Israel, Oct...

Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals

Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals PR Newswire REHOVOT...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.2-10.81081081081.851.851.561058001.71112526CS
4-0.9-35.29411764712.552.86991.567993432.23224079CS
12-1.71-50.89285714293.363.461.562922872.26783642CS
26-5.25-76.08695652176.98.9961.561894543.36471591CS
52-4.655-73.83029341796.30510.41.561714285.53612349CS
156-19.15-92.067307692320.821.41.561806569.35285331CS
260-12.45-88.297872340414.1102.3861.5634808033.86846274CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AALAmerican Airlines Group Inc
US$ 14,46
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 67,36
(0,00%)
0
AADIAadi Bioscience Inc
US$ 2,22
(0,00%)
0
AACGATA Creativity Global
US$ 1,02
(0,00%)
0
AALAmerican Airlines Group Inc
US$ 14,46
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 67,36
(0,00%)
0
AADIAadi Bioscience Inc
US$ 2,22
(0,00%)
0
AACGATA Creativity Global
US$ 1,02
(0,00%)
0
AALAmerican Airlines Group Inc
US$ 14,46
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 67,36
(0,00%)
0
AADIAadi Bioscience Inc
US$ 2,22
(0,00%)
0
AACGATA Creativity Global
US$ 1,02
(0,00%)
0
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock